TRIB3 and breast carcinoma: Studies have shown that the high expression of TRIB3 in breast cancer and oral squamous cell carcinoma indicated a better prognosis (Wennemers et al., 2011a; Zhang et al., 2011), but whether it can affect GC prognosis has not been confirmed.